Current Radiopharmaceuticals


Andrea Ciarmiello
Chief of Nuclear Medicine Unit and Imaging Department
S. Andrea Hospital
La Spezia

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 6 Issue: 3, September 2013


Volume:6   Issue: 3
Pp: i-i

DOI: 10.2174/1874471011306030001
Published on: 27 October, 2013

New Issues for Copper-64: from Precursor to Innovative Pet Tracers in Clinical Oncology

Volume:6   Issue: 3
Pp: 117-123
Laura Evangelista, Mansi Luigi and Giuseppe Lucio Cascini
DOI: 10.2174/18744710113069990020
Published on: 26 July, 2013

Gadolinium-Deferasirox-D-Glucosamine: Novel Anti-Tumor and MR Molecular (Theranostic) Imaging Agent

Volume:6   Issue: 3
Pp: 124-136
Massoud Amanlou, Hossein Mahian, Ahmad Molaei Rad, Seyed Ali Delbaz, Seyed Esmaeil Sadat Ebrahimi, Amir x Amir Javidi, Ali Jabbari Arabzadeh and Mehdi Shafiee Ardestani
DOI: 10.2174/18744710113069990019
Published on: 07 June, 2013

Mixed Tridentate π -Donor and Monodentate π -Acceptor Ligands as Chelating Systems for Rhenium-188 and Technetium-99m Nitrido Radiopharmaceuticals

Volume:6   Issue: 3
Pp: 137-145
Alessandra Boschi, Licia Uccelli, Micol Pasquali, Roberto Pasqualini, Remo Guerrini and Adriano Duatti
DOI: 10.2174/18744710113069990022
Published on: 29 August, 2013

Cellular Toxicity and Apoptosis Studies in Osteocarcinoma Cells, a Comparison of 177Lu-EDTMP and Lu-EDTMP

Volume:6   Issue: 3
Pp: 146-151
Chandan Kumar, Aruna Korde, Kusum V. Kumari, Tapas Das and Grace Samuel
DOI: 10.2174/18744710113069990021
Published on: 28 July, 2013

Targeted Radionuclide Therapy - An Overview

Volume:6   Issue: 3
Pp: 152-180
Ashutosh Dash, F. F. (Russ) Knapp and M. R.A. Pillai
DOI: 10.2174/18744710113066660023
Published on: 23 September, 2013